Enhanced solubility and functionality of valrubicin (AD-32) against cancer cells upon encapsulation into biocompatible nanoparticles
Nirupama Sabnis1, Maya Nair1, Mervyn Israel2, Walter J McConathy3, Andras G Lacko11University of North Texas Health Science Center, Fort Worth, TX, 2University of Tennessee Health Science Center, Memphis, TN, 3Texas Tech University Health Sciences Center–Permian Basin, Odessa, TX, USAA...
Main Authors: | Sabnis N, Nair M, Israel M, McConathy WJ, Lacko AG |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-02-01
|
Series: | International Journal of Nanomedicine |
Online Access: | http://www.dovepress.com/enhanced-solubility-and-functionality-of-valrubicin-ad-32-against-canc-a9318 |
Similar Items
-
The Potential Role of Nanotechnology in Therapeutic Approaches for Triple Negative Breast Cancer
by: Andras G. Lacko, et al.
Published: (2013-06-01) -
Exploring valrubicin’s effect on Propionibacterium acnes-induced skin inflammation in vitro and in vivo
by: Louise Rottboell, et al.
Published: (2015-12-01) -
DNA-binding studies of valrubicin as a chemotherapy drug using spectroscopy and electrochemical techniques
by: Reza Hajian, et al.
Published: (2017-06-01) -
HDL as a drug and nucleic acid delivery vehicle
by: Andras G Lacko, et al.
Published: (2015-10-01) -
Use of intravesical valrubicin in clinical practice for treatment of nonmuscle-invasive bladder cancer, including carcinoma of the bladder
by: Michael S. Cookson, et al.
Published: (2014-10-01)